398 related articles for article (PubMed ID: 17094904)
1. [Expression, purification, and serum antibody detection of HPV16 E6 in cervical cancer patients].
Gao YE; Guo JZ; Zhang J; Song TB; Yan XJ
Ai Zheng; 2006 Nov; 25(11):1374-9. PubMed ID: 17094904
[TBL] [Abstract][Full Text] [Related]
2. [Expression purification and clinical application of high-risk HPV16 E4 gene].
Gao YE; Hui H; Zhang J; Fan JB; Yan XJ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 33(8):676-81. PubMed ID: 18772505
[TBL] [Abstract][Full Text] [Related]
3. [Analysis on the expression of human papillomavirus type 16 E2 and E6 oncogenes and disruption of E2 in cervical cancer].
Wang JT; Ding L; Gao ES; Cheng YY
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):968-71. PubMed ID: 18399141
[TBL] [Abstract][Full Text] [Related]
4. HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China.
Qiu AD; Wu EQ; Yu XH; Jiang CL; Jin YH; Wu YG; Chen Y; Chen Y; Shan YM; Zhang GN; Fan Y; Zha X; Kong W
Gynecol Oncol; 2007 Jan; 104(1):77-85. PubMed ID: 16970982
[TBL] [Abstract][Full Text] [Related]
5. [Detection of HPV16 E6 gene in cervical tissues by quantitative polymerase chain reaction].
Ma CL; Li YJ; Zhang FC; Wang GQ; Zheng YJ; Kai LM; Re XD; Han Y; Patiguli
Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(6):469-73. PubMed ID: 15061964
[TBL] [Abstract][Full Text] [Related]
6. Vaccination of healthy volunteers with human papillomavirus type 16 L2E7E6 fusion protein induces serum antibody that neutralizes across papillomavirus species.
Gambhira R; Gravitt PE; Bossis I; Stern PL; Viscidi RP; Roden RB
Cancer Res; 2006 Dec; 66(23):11120-4. PubMed ID: 17145854
[TBL] [Abstract][Full Text] [Related]
7. [Human papillomavirus type 16 E6 oncogene and expression of P53, RB and PCNA in human cervical carcinoma].
Bian J; Yu X; Dong J; Zhao W; Zhou Y; Luan Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):271-3. PubMed ID: 15617346
[TBL] [Abstract][Full Text] [Related]
8. Serological study in Tunisian cervical cancer patients.
Achour M; Kochbati L; Zeghal D; Kahla S; Maalej M; Zouari F; Oueslati R
Pathol Biol (Paris); 2009 Jul; 57(5):415-9. PubMed ID: 18586408
[TBL] [Abstract][Full Text] [Related]
9. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
[TBL] [Abstract][Full Text] [Related]
10. [Detection of HPV 58 and cloning of its E7 gene in cervical cancer].
Gao YE; Zhang J; Chen ZC; Song TB; Zhao Y; Zhang GL; Yan XJ
Zhonghua Zhong Liu Za Zhi; 2004 Sep; 26(9):543-6. PubMed ID: 15555285
[TBL] [Abstract][Full Text] [Related]
11. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
de Boer MA; Jordanova ES; Kenter GG; Peters AA; Corver WE; Trimbos JB; Fleuren GJ
Clin Cancer Res; 2007 Jan; 13(1):132-8. PubMed ID: 17200347
[TBL] [Abstract][Full Text] [Related]
12. HPV16-specific cytotoxic T lymphocyte responses are detected in all HPV16-positive cervical cancer patients.
Valdespino V; Gorodezky C; Ortiz V; Kaufmann AM; Roman-Basaure E; Vazquez A; Berumen J
Gynecol Oncol; 2005 Jan; 96(1):92-102. PubMed ID: 15589586
[TBL] [Abstract][Full Text] [Related]
13. [Detection of HPV16 E6 gene in cervical tissues by quantitative polymerase chain reaction].
Luo B; Wang Y; Wang Y; Yu Q; Dai SZ; Wang B
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep; 15(3):248-50. PubMed ID: 11986698
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of protein expression feature and construction of procaryotic expression system for human papillomavirus type 16 (HPV-16) E4 gene].
Wang BN; Shi QF; Li H; Zhang WD; Zhuang YH; Yang J; Jiang ZH; Li MY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 May; 37(3):361-4. PubMed ID: 16761408
[TBL] [Abstract][Full Text] [Related]
15. Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.
Welters MJ; Kenter GG; Piersma SJ; Vloon AP; Löwik MJ; Berends-van der Meer DM; Drijfhout JW; Valentijn AR; Wafelman AR; Oostendorp J; Fleuren GJ; Offringa R; Melief CJ; van der Burg SH
Clin Cancer Res; 2008 Jan; 14(1):178-87. PubMed ID: 18172269
[TBL] [Abstract][Full Text] [Related]
16. A DNA vaccine constructed with human papillomavirus type 16 (HPV16) E7 and E6 genes induced specific immune responses.
Yan Q; Cheung YK; Cheng SC; Wang XH; Shi M; Hu MH; Yong X
Gynecol Oncol; 2007 Jan; 104(1):199-206. PubMed ID: 17049969
[TBL] [Abstract][Full Text] [Related]
17. [Reversal effect of antisense RNA targeting human papillomavirus 16 (HPV16) E6E7 on malignancy of human cervical cancer cell line SiHa].
Sima N; Wang W; Xu Q; Tian X; Luo AY; Lu YP; Wang SX; Ma D
Ai Zheng; 2007 Jan; 26(1):26-31. PubMed ID: 17222363
[TBL] [Abstract][Full Text] [Related]
18. DNA vaccine against human papillomavirus type 16: modifications of the E6 oncogene.
Poláková I; Pokorná D; Dusková M; Smahel M
Vaccine; 2010 Feb; 28(6):1506-13. PubMed ID: 20003917
[TBL] [Abstract][Full Text] [Related]
19. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
[TBL] [Abstract][Full Text] [Related]
20. [Human papillomavirus 16E6 gene mutation in cervical carcinoma tissues].
Sun F; Ha XQ; Lv TD; Xing CP; Liu B; Cao XZ
Ai Zheng; 2009 May; 28(5):478-82. PubMed ID: 19624874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
